The world of clinical research is witnessing a major shift. Sitero, a technology-forward Clinical Research Organization (CRO), has acquired the AI assets and business of studyOS. With this move, Sitero aims to lead the industry with its newly launched SiteroAI platform, designed to transform how global clinical trials are managed.
Sitero Acquires studyOS to Strengthen AI Clinical Solutions
The acquisition of studyOS, including its innovative AI Clinical Trial Agent, Ash, marks a crucial milestone for Sitero. By integrating advanced AI technology, Sitero reinforces its mission to blend operational excellence with technological innovation. Furthermore, key studyOS personnel, including CEO Ellis Butterfield, will join Sitero to ensure continuity and share their expertise. This strategic decision is set to boost Sitero’s regulatory-ready AI capabilities and enable seamless transitions for its clients.
Introducing SiteroAI: The First Fully AI-Powered CRO Platform
With the launch of SiteroAI, Sitero becomes the industry’s first truly AI-enabled CRO. The platform merges studyOS technology with the existing Mentor eClinical suite. As a result, SiteroAI is already delivering significant and measurable efficiency gains in real-world studies. The company projects that customers will achieve 20–30% efficiency improvements across the clinical development lifecycle by 2026. These gains are expected to cut study costs, improve time-to-market, and elevate data quality.
Enhanced Efficiency and Innovation in Global Clinical Trials
The addition of Ash’s AI-driven natural-language interface allows teams to query and automate trial workflows in real time. Thus, SiteroAI supports every stage of the clinical trial lifecycle—from study design to closeout. It provides capabilities such as:
- Automated data management and review
- Optimized clinical operations
- Improved sponsor oversight
Altogether, these tools empower sponsors and CRO partners to make faster, data-backed decisions and reduce clinical trial cycles worldwide.
In conclusion, Sitero’s acquisition of studyOS and the launch of SiteroAI mark a pivotal moment for clinical research technology. By combining innovative AI with expert service, Sitero is set to revolutionize the global clinical trial landscape, driving greater efficiency, quality, and speed for life sciences organizations everywhere.
Don’t miss our latest Startup News: Info-Tech’s CJIS Compliance Program Boosts Data Security Success
